Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02465268
Title Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme (ATTAC-II)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Florida
Indications

glioblastoma

Therapies

pp65 Dendritic Cell Vaccine + Sargramostim

Age Groups: adult
Covered Countries USA


No variant requirements are available.